We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 597

涉及药品标准的专利保护以四环制药与齐鲁制药之间的专利纠纷为视角
  • King & Wood Mallesons
  • China
  • February 15 2017

2017年1月北京四环制药有限公司下称“四环制药”在金杜知识产权诉讼团队的协助下获得一起专利侵权纠纷的


Particularity in the Inventiveness Evaluation of Chemical Composition Inventions
  • Beijing East IP Ltd
  • China
  • February 13 2017

Nippon Steel &Sumikin Stainless Steel v. The Patent Reexamination Board of SIPO (Administrative Judgement (2013) GAO Xing Zhong Zi No. 1754 by


Competitionantitrust law
  • Dentons
  • European Union, Germany, OECD, United Kingdom, USA, Australia, Canada, China
  • February 9 2017

In the wake of the 2016 elections, we now await the decision as to who will be the "antitrust guard" at the top of the US Department


Dentons' pick of global regulatory trends to watch in 2017
  • Dentons
  • Australia, Canada, China, European Union, Germany, Mexico, OECD, United Kingdom, USA
  • February 9 2017

Dentons’ team of regulatory lawyers from key jurisdictions around the world weigh in on regulatory trends to watch in 2017 in the US, Europe, the UK


中国知識産権局専利復審委員会 の復審無効事例紹介(2015)-3
  • King & Wood Mallesons
  • China
  • January 24 2017

前回に続き中国知識産権局専利復審委員会による2015年の復審無効十大判例の審決の概要と解説を行う


中国知識産権局専利復審委員会 の復審無効事例紹介(2015)-1
  • King & Wood Mallesons
  • China
  • January 24 2017

中国知識産権局専利復審委員会(以下復審委員会という)は2016年4月26日(世界知的所有権の日)に2015年の復審無効十大判例を発表した


中国知識産権局専利復審委員会 の復審無効事例紹介(2015)-2
  • King & Wood Mallesons
  • China
  • January 24 2017

前回に続き中国知識産権局専利復審委員会による2015年の復審無効十大判例のうち化学生物医薬分野の審決の概要と解説を行う


Expect the unexpected Patenting antibodies in Asia
  • FB Rice
  • China, Japan, South Korea
  • September 6 2016

Monoclonal antibodies are important human therapeutic agents and represent some of the largest selling drugs in the world. Patents relating to


Insight into recent PRB decisions on pharmaceutical biotech inventions
  • Peksung Intellectual Property Ltd
  • China
  • December 11 2015

The Patent Reexamination Board (hereinafter referred to as the PRB) is an organization under the SIPO (State Intellectual Property Office) of China


News and cases from China: August - September 2015
  • Rouse
  • China
  • October 29 2015

Recently, the National Copyright Administration issued Implementing Measures for the Copyright Administrative Penalties (Revision Draft for Comment